A Double-blind Trial of a Nicotine Inhaler for Smoking Cessation

Philip Tonnesen, MD, PhD; Jesper Nørregaard, MD; Kim Mikkelsen, MD; Stig Jorgensen, MD; Fredrik Nilsson, MSc
JAMA. 1993;269(10):1268-1271. doi:10.1001/jama.1993.03500100066029.
Text Size: A A A
Published online

Objective.  —To evaluate the efficacy of a new nicotine inhaler system for smoking cessation.

Design.  —A 1-year, randomized, double-blind, placebo-controlled study.

Setting.  —Medical outpatient clinic with physicians experienced in smoking cessation assistance.

Subjects.  —A total of 286 volunteers who smoked at least 10 cigarettes daily recruited through a local newspaper.

Intervention.  —Subjects were randomly allocated to nicotine inhalers (n=145) or placebo (n=141) to be used for 3 months followed by tapering for 3 months in the context of minimal levels of advice and support.

Main Outcome Measure.  —Continuous smoking abstinence at weeks 6, 12, 24, and 52, verified by measurements of carbon monoxide in expired air.

Results.  —Continuous smoking abstinence was significantly higher for the active nicotine inhaler group compared with the placebo inhaler group. The respective success rates were 28% and 12% after 6 weeks, 21% and 9% after 12 weeks, 17% and 8% after 6 months, and 15% and 5% after 1 year (P=.02 to.001). The mean nicotine substitution based on cotinine determinations after 2 weeks was 43% (SD, 45%) of smoking levels. The treatment was well tolerated, and no serious adverse events were reported.

Conclusions.  —In this setting the nicotine inhaler appeared safe to use and increased success rates of smoking cessation attempts.(JAMA. 1993;269:1268-1271)


Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours




Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.